FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns treating oxidative stress with using at least one bacterial strain possessing antioxidant properties, specified in Bifidobacterium lactis BS 05 (ID 1666) deposited in Probiotical SpA, Novara (Italy) in German collection of microorganisms and cell cultures (DSMZ) in Germany 13.10.2009 under deposition number DSM 23032; Lactobacillus acidophilus LA 06 (ID 1683) deposited in Probiotical SpA, Novara (Italy) in DSMZ in Germany 13.10.2009 under deposition number DSM 23033; and Lactobacillus brevis LBR01 (ID 1685) deposited in Probiotical SpA, Novara (Italy) in DSMZ in Germany 13.10.2009 under deposition number DSM 23034. The group of inventions also concerns a composition used in treating oxidative stress, containing at least one bacterial strain described above.
EFFECT: group of inventions provides treating oxidative stress.
17 cl, 8 ex, 2 dwg, 4 tbl
